Delgocitinib for Chronic Hand Eczema [ID12188]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Ruxolitinib for treating moderate atopic dermatitis [ID6602]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC